SATISH PATEL: Open Payments
NPI 1578728549 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,253 in 137 payments from 23 companies in 2025. Trend: 2023 $1,341 · 2024 $3,414 · 2025 $4,253
Food & beverage: $4,253
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 35 | $1,299 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $648 |
| Corcept Therapeutics | 18 | $453 |
| Lilly USA, LLC | 12 | $365 |
| Amgen Inc. | 6 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $170 |
| GlaxoSmithKline, LLC. | 3 | $151 |
| Exact Sciences Corporation | 6 | $123 |
| SANOFI-AVENTIS U.S. LLC | 1 | $121 |
Products named: JARDIANCE, FARXIGA, Korlym, BREZTRI, AIRSUPRA, Kerendia, MOUNJARO, CAPLYTA.
Industry payments across IL — which companies pay providers there.
